ライフサイエンスコーパス: collagen-induced arthritis

1 mechanical hyperalgesia and inflammation in collagen-induced arthritis.

2 h atRA suppressed progression of established collagen-induced arthritis.

3 odels of arthritis: Ab-induced arthritis and collagen-induced arthritis.

4 ining of joint tissue derived from mice with collagen-induced arthritis.

5 ts in a mouse model of autoimmune arthritis, collagen-induced arthritis.

6 llular and humoral immunity and the onset of collagen-induced arthritis.

7 re resistant to LPS-induced septic shock and collagen-induced arthritis.

8 and caspase-1(-/-) mice were susceptible to collagen-induced arthritis.

9 c T cells at the site of inflammation during collagen-induced arthritis.

10 ental autoimmune encephalomyelitis (EAE) and collagen-induced arthritis.

11 c (Tg) mice expressing HLA-DRB1*0401 develop collagen-induced arthritis.

12 ed animals in a systemic model of RA disease collagen-induced arthritis.

13 as attenuated disease in MRL/lpr mice and in collagen-induced arthritis.

14 Salmonella-CFA/I can protect DBA/1 mice from collagen-induced arthritis.

15 d its impact on the clinical model of bovine collagen-induced arthritis.

16 a T cells have also been found to exacerbate collagen-induced arthritis.

17 ptor family has a role in the progression of collagen-induced arthritis.

18 reduced the clinical and histologic signs of collagen-induced arthritis.

19 mmune mice, including T cells from mice with collagen-induced arthritis.

20 for B cells during the elicitation phase of collagen-induced arthritis.

21 of experimental models of arthritis, such as collagen-induced arthritis.

22 use anti-mouse CD20 mAbs in a mouse model of collagen-induced arthritis.

23 ively correlated with paw swelling in murine collagen-induced arthritis.

24 optosis in thymocytes and pre-disposition to collagen-induced arthritis.

25 reduce the incidence and severity of murine collagen-induced arthritis.

26 efficacy in some animal models, most notably collagen-induced arthritis.

27 tic effect of sST2-Fc in the murine model of collagen-induced arthritis.

28 ansgenic mice that display susceptibility to collagen-induced arthritis.

29 of arthritis and in its ability to suppress collagen-induced arthritis.

30 therapeutic evaluation in a murine model of collagen-induced arthritis.

31 rotective, whereas loss of IL-12 exacerbates collagen-induced arthritis.

32 nase 9 on the development and progression of collagen-induced arthritis.

33 ice susceptible to porcine and human type II collagen-induced arthritis.

34 xperimental autoimmune encephalomyelitis and collagen-induced arthritis.

35 ad the capacity to prevent and/or ameliorate collagen-induced arthritis.

36 tage and IgG2a Ab's at the effector phase of collagen-induced arthritis.

37 pared following induction of monoclonal anti-collagen-induced arthritis.

38 are normally susceptible to the induction of collagen-induced arthritis.

39 d particles inhibited development of type II collagen-induced arthritis.

40 combined anti-TNF-alpha/anti-CD4 therapy in collagen-induced arthritis.

41 lays a more prominent role than IL-1alpha in collagen-induced arthritis.

42 o strongly alleviated disease development in collagen-induced arthritis.

43 exposure-dependent fashion in a rat model of collagen-induced arthritis.

44 immunocytokine F8-IL4 in the mouse model of collagen-induced arthritis.

45 ria significantly aggravated the severity of collagen-induced arthritis.

46 8-IL4 was able to cure mice with established collagen-induced arthritis.

47 on of arthritis in the experimental model of collagen-induced arthritis.

48 hase that contributes to the pathogenesis of collagen-induced arthritis, a disease model of human rhe

49 act of TNF inhibition on IL-17 production in collagen-induced arthritis, a model of RA.

50 (EGFR), reduces the severity of established collagen-induced arthritis, a mouse model of RA, and tha

51 e the contribution of NK cells to regulating collagen-induced arthritis, a well-characterized preclin

52 60(p216) but not Qa-1-Qdm strongly inhibited collagen-induced arthritis, an animal model of human rhe

53 close analog, SNX-4414, was evaluated in rat collagen-induced arthritis and adjuvant-induced arthriti

54 In collagen-induced arthritis and Ag-induced arthritis, alt

55 s of T15-NAb also efficiently inhibited both collagen-induced arthritis and anti-collagen II Ab-media

56 gen-specific CD4(+) T cell expansion in both collagen-induced arthritis and autoimmune diabetes mouse

57 BA/1 background were completely resistant to collagen-induced arthritis and exhibited absence of join

58 rity of the inflammatory autoimmune diseases collagen-induced arthritis and experimental autoimmune e

59 imal models of inflammatory diseases such as collagen-induced arthritis and experimental autoimmune e

60 the inflamed joint in arthritis in mice with collagen-induced arthritis and humans with RA.

61 in experimental allergic encephalomyelitis, collagen-induced arthritis and inflammatory bowel diseas

62 ved dendritic cells and in vivo in models of collagen-induced arthritis and inflammatory bowel diseas

63 miR-34a-deficient mice are resistant to collagen-induced arthritis and interaction of DCs and T

64 mit the incidence of arthritis in a model of collagen-induced arthritis and joint inflammation.

65 ese data indicate that ICOS is essential for collagen-induced arthritis and may suggest novel means f

66 d and activated in the synovium of mice with collagen-induced arthritis and patients with RA.

67 re increased in the lymph nodes of mice with collagen-induced arthritis and SLE.

68 ed up-regulation, mice developed more severe collagen-induced arthritis and spontaneous glomerular im

69 of disease severity and early onset in both collagen-induced arthritis and spontaneous lupus nephrit

70 IL-deficient mice are also hypersensitive to collagen-induced arthritis and streptozotocin-induced di

71 itis and its neutralization inhibited murine collagen-induced arthritis and suppressed IFN-gamma and

72 n that is up-regulated in the early stage of collagen-induced arthritis and that exacerbates arthriti

73 exhibited significantly reduced severity of collagen-induced arthritis and this was accompanied by a

74 PGRN-deficient mice were susceptible to collagen-induced arthritis, and administration of PGRN r

75 essed LPS-induced TNF production, alleviated collagen-induced arthritis, and blocked gout formation i

76 In contact hypersensitivity, collagen-induced arthritis, and inflammation induced by

77 odent models of polyarthritis: rat and mouse collagen-induced arthritis, and mouse collagen antibody-

78 sitivity model, suppress the onset on murine collagen-induced arthritis, and reduce the severity of e

79 mmune disease: systemic lupus erythematosus, collagen-induced arthritis, and serum-transfer arthritis

80 ted intravenously into mice with established collagen-induced arthritis, and the effects on leukocyte

81 essfully but had increased susceptibility to collagen-induced arthritis, and the levels of huTLR8 cor

82 osomes was able suppress the onset of murine collagen-induced arthritis as well as reduce severity of

83 iency of mPGES-1 inhibits the development of collagen-induced arthritis, at least in part, by blockin

84 their ability to prevent the development of collagen induced arthritis, both the engineered DR1-CII-

85 luorescence in arthritic joints of mice with collagen-induced arthritis by both noninvasive fluoresce

86 I vaccination of DBA/1 mice protects against collagen-induced arthritis by stimulating TGF-beta- and

87 of EC144 blocked disease development in rat collagen-induced arthritis by suppressing the inflammato

88 that IL-4 DCs exert a therapeutic effect on collagen-induced arthritis by targeting IL-17.

89 s study was to investigate the regulation of collagen-induced arthritis by tryptophan catabolism medi

90 iator for PGRN-mediated anti-inflammation in collagen-induced arthritis by using PGRN and IL-10 genet

91 models of autoimmune disease; in particular, collagen induced arthritis (CIA) and experimental autoim

92 Collagen induced arthritis (CIA) is an animal model of R

93 acious (ED(50) < or = 0.01 mg/kg) in the rat collagen induced arthritis (CIA) model.

94 efficacious (ED 50 = 0.05 mg/kg) in the rat collagen induced arthritis (CIA) model.

95 s marked changes in the preclinical phase of collagen induced arthritis (CIA).

96 y modified DC to suppress established murine collagen-induced arthritis (CIA) after i.v. delivery.

97 nd growth of bony spurs was performed in rat collagen-induced arthritis (CIA) and adjuvant-induced ar

98 level was dramatically elevated during mouse collagen-induced arthritis (CIA) and blocking TWEAK by a

99 complementary experimental RA mouse models, collagen-induced arthritis (CIA) and collagen antibody-i

100 letely halts and reverses the development of collagen-induced arthritis (CIA) and discover cellular a

101 SSRIs, fluoxetine and citalopram, in murine collagen-induced arthritis (CIA) and in a human ex vivo

102 n vivo mechanism of action was determined in collagen-induced arthritis (CIA) and local joint TLR5 li

103 Collagen-induced arthritis (CIA) and proteoglycan-induce

104 3 receptor alpha-chain, developed attenuated collagen-induced arthritis (CIA) and reduced ex vivo col

105 the development of pain in the rat model of collagen-induced arthritis (CIA) and to evaluate the con

106 her mucosal administration of EtxB can block collagen-induced arthritis (CIA) and to investigate the

107 perimental autoimmune encephalomyelitis, and collagen-induced arthritis (CIA) are associated with typ

108 actor Ag I (CFA/I) fimbriae protects against collagen-induced arthritis (CIA) by eliciting two regula

109 keyhole limpet hemocyanin (KLH) study and a collagen-induced arthritis (CIA) disease model of rheuma

110 s in RA, NK cells in the joints of mice with collagen-induced arthritis (CIA) express RANKL.

111 dy to test the hypothesis that resistance to collagen-induced arthritis (CIA) in C57BL/6 (B6) mice is

112 he objective of these studies was to examine collagen-induced arthritis (CIA) in C57BL/6 mice transge

113 stress protein, BiP, prevented induction of collagen-induced arthritis (CIA) in HLA-DRB*0101+/+ (HLA

114 Adjuvant-induced arthritis (AIA) and collagen-induced arthritis (CIA) in Lewis rats were used

115 he IL-15R on the prevention and treatment of collagen-induced arthritis (CIA) in mice and probed the

116 of a soluble ligand of CD200R in established collagen-induced arthritis (CIA) in mice and to analyze

117 We report herein that collagen-induced arthritis (CIA) in mice is inhibited by

118 A major difference between RA in humans and collagen-induced arthritis (CIA) in mice is the lack of

119 Collagen-induced arthritis (CIA) in mice is widely used

120 r interaction precipitated susceptibility to collagen-induced arthritis (CIA) in mice normally resist

121 te the significance of these autoantibodies, collagen-induced arthritis (CIA) in mice was used to est

122 inhibitor BMS-345541 is efficacious against collagen-induced arthritis (CIA) in mice.

123 Collagen-induced arthritis (CIA) is a model of inflammat

124 Collagen-induced arthritis (CIA) is a polygenic model of

125 The murine model of collagen-induced arthritis (CIA) is an established disea

126 Rat collagen-induced arthritis (CIA) is an experimental mode

127 MSCs transplantation (MSCT) into collagen-induced arthritis (CIA) mice prevented arthriti

128 ll depletion was further studied in a murine collagen-induced arthritis (CIA) model and a respiratory

129 The collagen-induced arthritis (CIA) model and DR-1 transgen

130 Oral efficacy in the murine collagen-induced arthritis (CIA) model for rheumatoid ar

131 s (PADs), are known to develop in the murine collagen-induced arthritis (CIA) model of inflammatory a

132 asts and pathological bone loss in the mouse collagen-induced arthritis (CIA) model of RA.

133 In a collagen-induced arthritis (CIA) model, neovascularizati

134 In this study we show, using the DBA/1 collagen-induced arthritis (CIA) model, that conjugation

135 Using the collagen-induced arthritis (CIA) model, we have studied

136 In the collagen-induced arthritis (CIA) model, while ectopic ex

137 nti-arthritic effect of engineered MSCs in a collagen-induced arthritis (CIA) model.

138 o evaluate MKK-3 and MKK-6 deficiency in the collagen-induced arthritis (CIA) model.

139 n vitro and to control disease severity in a collagen-induced arthritis (CIA) model.

140 itic joints of TSG-6 transgenic mice, in the collagen-induced arthritis (CIA) model.

141 ro, and joint inflammation and damage in the collagen-induced arthritis (CIA) model.

142 the role of CRP in a mouse model of RA, the collagen-induced arthritis (CIA) model.

143 sing delayed-type hypersensitivity (DTH) and collagen-induced arthritis (CIA) models in mice.

144 The collagen-induced arthritis (CIA) mouse model is the most

145 r (uPA) reduces arthritis progression in the collagen-induced arthritis (CIA) mouse model to an exten

146 We used a collagen-induced arthritis (CIA) mouse model to study th

147 ) and the development of bone erosion in the collagen-induced arthritis (CIA) mouse.

148 of wild type (WT) versus CRIg(-/-) mice with collagen-induced arthritis (CIA) or K/BxN serum transfer

149 nvadosomal structures by synovial cells from collagen-induced arthritis (CIA) rats and RA patients.

150 Collagen-induced arthritis (CIA) represents an animal mo

151 Collagen-induced arthritis (CIA) represents an animal mo

152 of the MEK/ERK MAP kinase pathway in murine collagen-induced arthritis (CIA) using the selective MEK

153 Passive collagen-induced arthritis (CIA) was induced in Jnk2(-/-

154 Collagen-induced arthritis (CIA) was induced in male DBA

155 In these studies, collagen-induced arthritis (CIA) was induced in P-select

156 t and to identify their mechanism of action, collagen-induced arthritis (CIA) was therapeutically tre

157 This study in mice with established collagen-induced arthritis (CIA) was undertaken to deter

158 All pathological features of collagen-induced arthritis (CIA) were significantly redu

159 h carrageenan-induced acute inflammation and collagen-induced arthritis (CIA) were used to assess eff

160 the ability of these cells to control murine collagen-induced arthritis (CIA), a model for rheumatoid

161 Although the pathogenesis of collagen-induced arthritis (CIA), a model of rheumatoid

162 lator of inflammation was examined in murine collagen-induced arthritis (CIA), a model of rheumatoid

163 e such product, ES-62, is protective against collagen-induced arthritis (CIA), a model of rheumatoid

164 inflammation, contribute to the progress of collagen-induced arthritis (CIA), a mouse model for RA.

165 toring and quantifying joint inflammation in collagen-induced arthritis (CIA), a mouse model for RA.

166 ene knockout (KO) mice to assess its role in collagen-induced arthritis (CIA), a mouse model of human

167 arthritis shows any similarities with RA or collagen-induced arthritis (CIA), a mouse model of RA.

168 mmunoregulatory protein for the treatment of collagen-induced arthritis (CIA), a mouse model of rheum

169 ets, Vgamma1(+) and Vgamma4(+) cells, during collagen-induced arthritis (CIA), a mouse model that sha

170 eptibility of CD73-deficient C57BL/6 mice to collagen-induced arthritis (CIA), a well-established mou

171 table for use in DBA/1LacJ mice that develop collagen-induced arthritis (CIA), an animal model of hum

172 and evaluated their therapeutic potential in collagen-induced arthritis (CIA), an animal model of RA.

173 markedly increased during the acute stage of collagen-induced arthritis (CIA), an animal model of rhe

174 elayed the onset and reduced the severity of collagen-induced arthritis (CIA), and reduced paw tissue

175 immune responses, led to early resolution of collagen-induced arthritis (CIA), and reduced spontaneou

176 In collagen-induced arthritis (CIA), preventive and therape

177 Upon induction of collagen-induced arthritis (CIA), tau-tg mice displayed

178 In mice with collagen-induced arthritis (CIA), the disease-modulating

179 We assessed pain behavior and mechanisms in collagen-induced arthritis (CIA), the model of preclinic

180 When transferred into mice with collagen-induced arthritis (CIA), this T cell line speci

181 cient in IL-1Ra (IL-1Ra(-/-)) were bred with collagen-induced arthritis (CIA)-susceptible DBA/1 mice

182 a therapeutic agent was evaluated in murine collagen-induced arthritis (CIA).

183 cally delivered into the ankles of mice with collagen-induced arthritis (CIA).

184 matory joint disease in mice challenged with collagen-induced arthritis (CIA).

185 was down-modulated during the progression of collagen-induced arthritis (CIA).

186 in the chronic inflammatory arthritis model collagen-induced arthritis (CIA).

187 is adaptor is required for the initiation of collagen-induced arthritis (CIA).

188 g an anti-mouse CD70 Ab in a murine model of collagen-induced arthritis (CIA).

189 Administration of misoprostol exacerbated collagen-induced arthritis (CIA).

190 motif (FibgammaDelta5), were challenged with collagen-induced arthritis (CIA).

191 in a model of rheumatoid arthritis, namely, collagen-induced arthritis (CIA).

192 imatinib potently prevents and treats murine collagen-induced arthritis (CIA).

193 emonstrated that p53 is protective in murine collagen-induced arthritis (CIA).

194 J mice to study the role of CD44 directly in collagen-induced arthritis (CIA).

195 8.CD4(-/-) mice were resistant to developing collagen-induced arthritis (CIA).

196 with bovine type II collagen (CII) to elicit collagen-induced arthritis (CIA).

197 uated in cultured Jurkat cells and in murine collagen-induced arthritis (CIA).

198 ion, including rheumatoid arthritis (RA) and collagen-induced arthritis (CIA).

199 anti-inflammatory proteins that can suppress collagen-induced arthritis (CIA).

200 omyelitis, diabetes, and, in our laboratory, collagen-induced arthritis (CIA).

201 used to locate CRIg expression in mice with collagen-induced arthritis (CIA).

202 testing in an in vivo model of inflammation, collagen-induced arthritis (CIA).

203 destructive arthritis in the murine model of collagen-induced arthritis (CIA).

204 collagen and yet have a reduced incidence of collagen-induced arthritis (CIA).

205 using a mouse model of autoimmune arthritis, collagen-induced arthritis (CIA).

206 ed natural Treg (nTreg) cells on established collagen-induced arthritis (CIA).

207 ed in human rheumatoid arthritis (RA) and in collagen-induced arthritis (CIA).

208 response gene with CII elicits an arthritis (collagen-induced arthritis [CIA]) that resembles rheumat

209 nificantly reduced incidence and severity of collagen-induced arthritis compared with wild-type (WT)

210 In collagen-induced arthritis, deficiency of endogenous Anx

211 In addition, 31 demonstrated efficacy in a collagen-induced arthritis disease model in rats.

212 nic mice developed more severe and sustained collagen-induced arthritis due to the enhanced Th1 respo

213 We demonstrated that murine collagen-induced arthritis follows a similar sequential

214 3, ASC, and caspase-1 in the pathogenesis of collagen-induced arthritis have not been characterized.

215 arthritis, IFN-gamma is required, whereas in collagen-induced arthritis, IL-17 is necessary for devel

216 , HNK stabilized the severity of symptomatic collagen-induced arthritis in both CD40-LMP1 transgenic

217 elayed the onset and reduced the severity of collagen-induced arthritis in DBA/1 mice by induction of

218 n DBA/1-TCR-beta transgenic mice, as well as collagen-induced arthritis in DBA/1 mice, both animal mo

219 vivo in an autoimmune disease model, namely, collagen-induced arthritis in DBA/1 mice.

220 e autoimmune inflammatory process of chronic collagen-induced arthritis in DBA/1-TCR-beta transgenic

221 We showed that this peptide ameliorates collagen-induced arthritis in DBA/1J mice and protects a

222 i-inflammation could be unveiled by studying collagen-induced arthritis in Gal-1(-/-) mice.

223 protein LTbetaR-Ig blocked the induction of collagen-induced arthritis in mice and adjuvant arthriti

224 nistration of ERG240 reduces the severity of collagen-induced arthritis in mice and crescentic glomer

225 eptide significantly reduced the severity of collagen-induced arthritis in mice by reducing levels of

226 25 in vivo down-regulates the progression of collagen-induced arthritis in mice via targeting of the

227 8 kinase activities and clinical symptoms of collagen-induced arthritis in mice were all diminished.

228 itis in the models of adjuvant arthritis and collagen-induced arthritis in rats and mice, respectivel

229 Susceptibility to experimental collagen-induced arthritis in rodents is dependent on MH

230 on of DRB1*0402 did not lead to induction of collagen-induced arthritis in transgenic mice.

231 We studied serotonin's involvement during collagen-induced arthritis in wild-type and Tph1(-/-) mi

232 ne models of chronic inflammation, including collagen-induced arthritis, inflammatory bowel disease,

233 Collagen-induced arthritis is a commonly accepted model

234 Chronic relapsing homologous collagen-induced arthritis is a valuable model for ident

235 Collagen-induced arthritis is a well-validated, but stra

236 4) enhanced Th17 expansion, and in mice with collagen-induced arthritis it facilitated disease onset,

237 ecule on T lymphocytes, CD40(+) T cells from collagen-induced arthritis mice were examined in paralle

238 so potent in treating established disease in collagen-induced arthritis mice with beneficial effects

239 eutic action of tolerogenic DCs in a type II collagen-induced arthritis model and to investigate thei

240 rat and dog and was found to be active in a collagen-induced arthritis model in rats.

241 ing of GLPG0634 in a therapeutic set-up in a collagen-induced arthritis model in rodents resulted in

242 n vivo, because inhibition of C5orf30 in the collagen-induced arthritis model markedly accentuated jo

243 odel of systemic lupus erythematosus and the collagen-induced arthritis model of rheumatoid arthritis

244 We used the murine collagen-induced arthritis model to characterize the imm

245 cells to the inflammatory site, we used the collagen-induced arthritis model to determine the freque

246 mice, but not DBA/1J (the strain used in the collagen-induced arthritis model) or DBA/2J mice.

247 fficacy in adjuvant-induced arthritis model, collagen-induced arthritis model, and allergic asthma mo

248 In a mouse collagen-induced arthritis model, EC144 also suppressed

249 In a prophylactic collagen-induced arthritis model, it exhibited an anti-i

250 In a murine collagen-induced arthritis model, JNJ-54271074 dose-depe

251 xin-1 increased skewing in Th1 cells; in the collagen-induced arthritis model, treatment of mice with

252 In the type II collagen-induced arthritis model, we observed a signific

253 ion and cartilage destruction in this murine collagen-induced arthritis model.

254 m 50 to 80% and is milder than the classical collagen-induced arthritis model.

255 role of ICOS in rheumatoid arthritis using a collagen-induced arthritis model.

256 /PD assays and highly efficacious in a mouse collagen-induced arthritis model.

257 Efficacy of GLPG0634 in the collagen-induced arthritis models was comparable to the

258 Here, we examine the therapeutic effects in collagen-induced arthritis of the second generation PAD

259 In a model of collagen-induced arthritis on the C57BL/6 background, th

260 e, IL-35 inhibited clinical manifestation of collagen-induced arthritis or could cease further diseas

261 ntigens emulsified in adjuvant oils, such as collagen-induced arthritis or experimental autoimmune en

262 of the disease (as appears to be the case in collagen-induced arthritis) or T cells are required for

263 In mice with collagen-induced arthritis, orally administered PCI-3276

264 Remarkably, the collagen-induced arthritis phenotype of Ccr2-/- mice mim

265 kine analysis shows that mice protected from collagen-induced arthritis produce lower amounts of Th1

266 n up to 1 month before the clinical onset of collagen-induced arthritis protected mice from severe jo

267 -AIA in DA.F344 monocongenic rats containing collagen-induced arthritis QTLs.

268 Treatment of mice with established collagen-induced arthritis reduced the severity of arthr

269 s biomarkers in RA, enhance tissue damage in collagen-induced arthritis (see the related article begi

270 Crucially, ES-62 was also found to suppress collagen-induced arthritis severity and progression when

271 tained anti-inflammatory activity in vivo in collagen induced arthritis studies in mouse but had redu

272 Collagen induced arthritis studies in mouse have demonst

273 In paws taken from the collagen-induced arthritis study, the bones of vehicle-t

274 DBA/2J) to investigate the genetic basis of collagen-induced arthritis susceptibility.

275 This motif is similar to one recognized by collagen-induced arthritis-susceptible HLA-DR1- and HLA-

276 Using a novel collagen-induced arthritis synovial window model, we dem

277 hat Fas-deficient mice developed less-severe collagen-induced arthritis than did control mice.

278 When administered in vivo to mice with collagen-induced arthritis, the SE ligand significantly

279 es are a prerequisite for the development of collagen-induced arthritis, their presence is insufficie

280 ivo studies were conducted in a rat model of collagen-induced arthritis to evaluate the therapeutic p

281 The effect of IDO deficiency on collagen-induced arthritis was assessed in vivo by admin

282 signal, a TCR-transgenic (Tg) mouse model of collagen-induced arthritis was developed.

283 ed disease, the efficacy of rh-FcgammaRIA in collagen-induced arthritis was evaluated.

284 Collagen-induced arthritis was induced in mice hypomorph

285 In addition, we report that collagen-induced arthritis was not affected by the funct

286 While analyzing gene expression in collagen-induced arthritis, we discovered that a poorly

287 termine the role CD28 costimulation plays in collagen-induced arthritis, we have generated DQ8 transg

288 In a model of collagen-induced arthritis, we use S100A8/S100A9 imaging

289 ation, late phase cutaneous anaphylaxis, and collagen-induced arthritis were aggravated, in contrast

290 T cell activation and its ability to prevent collagen-induced arthritis were analyzed.

291 Penetrance, onset, and severity of collagen-induced arthritis were recorded in DUSP-1+/+ an

292 The incidence and severity of collagen-induced arthritis were significantly reduced an

293 Mice with collagen-induced arthritis were treated with depleting a

294 Male DBA/1J mice with collagen-induced arthritis were treated with etanercept.

295 models of delayed-type hypersensitivity and collagen-induced arthritis were used.

296 er inflammation of the knee joints following collagen-induced arthritis, when compared with control m

297 *0401 gene contributes to the development of collagen-induced arthritis, whereas DRB1*0402 prevents t

298 ays a dominant role in the susceptibility to collagen-induced arthritis, whereas FcgammaRIIb on B cel

299 ent development of inflammation in mice with collagen-induced arthritis, whereas sorted CD25+CD39+CD4

300 DQ8.CD28(-/-) mice develop collagen-induced arthritis with delayed onset and less s